The World Health Organization (WHO) has officially certified Denmark for the elimination of mother-to-child transmission (EMTCT) of both HIV and syphilis, marking a historic achievement in the realm of global public health. This certification recognizes Denmark’s long-standing and unwavering commitment to ensuring that every child within its borders is born free of these life-altering infections. By meeting the rigorous international standards for validation, Denmark has not only secured the health of its future generations but has also established itself as a pioneer within the European Union, becoming the first member state to reach this specific public health milestone.
The formal recognition follows a comprehensive assessment conducted by the WHO’s Regional Validation Committee in June 2025, followed by a final review by the Global Validation Advisory Committee (GVAC) in August 2025. These evaluations confirmed that Denmark successfully met all required targets and benchmarks between 2021 and 2024. These criteria included maintaining exceptionally low transmission rates and ensuring high levels of coverage for prenatal testing and clinical treatment for pregnant women. The achievement is the culmination of decades of strategic investment in primary care, maternal health, and a robust, integrated public health infrastructure.
A Landmark Achievement in Global Health
The elimination of mother-to-child transmission, often referred to as "vertical transmission," is one of the most significant goals in the global fight against HIV and sexually transmitted infections (STIs). Dr. Tedros Adhanom Ghebreyesus, the Director-General of the WHO, lauded the achievement as a testament to what is possible when political will aligns with consistent healthcare investment. According to Dr. Tedros, this milestone demonstrates that with strong political commitment and consistent investment in primary care and integrated maternal and child health services, countries can protect every pregnant woman and newborn from these diseases.
For Denmark, the certification is more than just a badge of honor; it is a validation of the "Danish Model" of healthcare, which emphasizes universal access, equality, and high-quality data systems. Dr. Hans Henri P. Kluge, the WHO Regional Director for Europe, highlighted the specific benchmarks Denmark surpassed to earn this distinction. Elimination, in the context of WHO validation, requires a country to test and treat at least 95 out of every 100 pregnant women and to keep new infant infections below a threshold of 50 per 100,000 births consistently over several years. Denmark’s ability to meet and maintain these benchmarks is attributed to its strong antenatal care programs, reliable laboratory capacity, and a deep-seated respect for women’s reproductive rights.
The Path to Validation: Data and Methodology
The validation process for EMTCT is famously rigorous, requiring countries to provide verifiable data that spans several years. The WHO’s Global Validation Advisory Committee looks for evidence of high-impact interventions that are integrated into the broader health system rather than being managed as isolated projects.
In Denmark, the health system’s ability to track every pregnancy and ensure that screening is routine and stigma-free was a decisive factor. The country’s data systems allowed for precise monitoring of the "cascade of care"—the process from the initial diagnosis of a pregnant woman to her treatment and the eventual testing of the infant. Between 2021 and 2024, Denmark demonstrated that its prenatal screening coverage remained near-universal. By integrating HIV and syphilis testing into the first trimester of prenatal care, the Danish health system ensures that interventions can begin as early as possible, which is the most effective way to prevent transmission to the fetus.
Statistical Context and Public Health Landscape
To understand the magnitude of Denmark’s success, it is necessary to examine the underlying epidemiology of HIV and syphilis within the country. Denmark maintains relatively low rates of these infections compared to global averages, yet the challenge of maintaining "zero transmission" remains complex.
Currently, approximately 5,950 people are living with HIV in Denmark. Among the pregnant population, the prevalence of HIV is exceptionally low, affecting less than 0.1% of women. Despite these low numbers, the risk of vertical transmission is always present without a robust screening system. Through routine testing and the immediate administration of antiretroviral therapy (ART) for HIV-positive mothers, Denmark has effectively reduced mother-to-child transmission rates to zero.
Syphilis presents a different set of challenges, as the infection can often be asymptomatic in women but devastating to a developing fetus, leading to congenital syphilis, which can cause stillbirth, neonatal death, or severe physical and neurological disabilities. In 2024, Denmark reported 626 cases of syphilis overall. The majority of these cases—524—were among men, while 102 cases were reported in women. Despite the presence of the bacteria in the general population, the systematic nature of Danish prenatal screening ensures that syphilis is caught and treated with penicillin well before it can be passed to the infant.
The Role of Universal Healthcare and Human Rights
At the heart of Denmark’s success is its universal health system, which is built on the principle of equal access for all residents, regardless of their socioeconomic status or background. Sophie Løhde, Denmark’s Minister for the Interior and Health, emphasized that this achievement is the result of decades of work by healthcare professionals, including midwives, nurses, and public health specialists.
"Denmark’s universal health system—built on equal access for all—has been the foundation of this achievement," Løhde stated. She noted that being the first EU country to reach this milestone is both an honor and a responsibility. The Danish approach is characterized by a "rights-based" policy framework. This means that healthcare is not only accessible but is delivered in a way that respects the autonomy and privacy of the patient. By removing barriers to care and reducing the stigma associated with HIV and STIs, Denmark has created an environment where pregnant women feel safe seeking the testing and treatment they need.
The role of the midwife in the Danish system is particularly noteworthy. Midwives are the primary point of contact for most pregnant women in Denmark, providing a continuity of care that fosters trust and ensures that no woman "falls through the cracks" of the medical system.
Looking Ahead: The Goal of Triple Elimination
While the certification for HIV and syphilis is a major victory, the Danish government and the WHO are already looking toward the next frontier: "Triple Elimination." This initiative aims to eliminate the mother-to-child transmission of three key infections: HIV, syphilis, and the hepatitis B virus (HBV).
Denmark is already well on its way to validating the elimination of HBV. Currently, the prevalence of chronic hepatitis B infection in Denmark is estimated to be around 0.2% to 0.3%. The majority of these cases are found among migrant populations from regions where HBV is endemic. To tackle this, Denmark has implemented targeted screening and vaccination programs to prevent mother-to-child transmission of the virus.
The WHO is currently working closely with Danish health authorities to advance the triple elimination validation process. Reaching this next goal would make Denmark one of the few countries in the world to have successfully addressed all three major vertical transmission threats, providing a comprehensive "triple shield" for newborns.
Denmark in the Global Context
By achieving this certification, Denmark joins a select group of 22 other countries and territories that have been validated by the WHO for the elimination of mother-to-child transmission of HIV, syphilis, or hepatitis B. This group includes a diverse range of nations such as Cuba (the first to be validated in 2015), Thailand, Malaysia, Sri Lanka, Oman, and several Caribbean nations like Antigua and Barbuda and Saint Kitts and Nevis.
The inclusion of Denmark is significant because it provides a blueprint for other high-income, Western nations. While many developing countries have made strides in EMTCT through focused international aid, Denmark’s success shows how a mature, taxpayer-funded healthcare system can sustain these results over the long term through internal efficiency and social policy.
Implications for the European Union and Beyond
As the first EU country to receive this certification, Denmark’s experience is expected to serve as a catalyst for other member states. The WHO Regional Office for Europe has indicated that it will use the Danish model to inspire and support other countries in the region.
The success in Denmark highlights several key lessons for the global health community:
- Integration is Key: Screening and treatment must be a standard part of maternal care, not a separate "opt-in" service.
- Data Integrity: Robust laboratory and reporting systems are essential for identifying gaps in care and proving success to international bodies.
- Universal Access: Eliminating transmission is nearly impossible if marginalized populations do not have the same access to care as the general public.
- Sustained Investment: EMTCT is not a one-time project but a permanent requirement of a high-functioning health system.
Denmark’s journey toward elimination has been a marathon, not a sprint. It reflects decades of clinical excellence and a societal commitment to the health of the most vulnerable. As the country moves toward the final hurdle of hepatitis B elimination, the global health community will continue to look toward Copenhagen as a beacon of what can be achieved through science, solidarity, and a steadfast commitment to human rights.